Oropharyngeal Carcinoma with a Special Focus on HPV-Related Squamous Cell Carcinoma

Overview

Journal Annu Rev Pathol

Publisher Annual Reviews

Specialty Pathology

Date 2023 Jan 24

PMID 36693202

Authors

Robert L Ferris

William Westra

Affiliations

Soon will be listed here.

Abstract

Human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV-OPSCC) has one of the most rapidly increasing incidences of any cancer in high-income countries. The most recent (8th) edition of the Union for International Cancer Control/American Joint Committee on Cancer staging system separates HPV-OPSCC from its HPV-negative counterpart to account for the improved prognosis seen in the former. Indeed, owing to its improved prognosis and greater prevalence in younger individuals, numerous ongoing trials are examining the potential for treatment deintensification as a means to improve quality of life while maintaining acceptable survival outcomes. Owing to the distinct biology of HPV-OPSCCs, targeted therapies and immunotherapies have become an area of particular interest. Importantly, OPSCC is often detected at an advanced stage, highlighting the need for diagnostic biomarkers to aid in earlier detection. In this review, we highlight important advances in the epidemiology, pathology, diagnosis, and clinical management of HPV-OPSCC and underscore the need for a progressive understanding of the molecular basis of this disease toward early detection and precision care.

Citing Articles

Prognostic value of human papilloma virus (HPV) status and programmed cell death ligand 1 (PD-L1) status in oral tongue cancer.

Szewczyk M, Ostapowicz J, Piotrowski I, Ostrowska K, Suchorska W, Golusinski W Contemp Oncol (Pozn). 2025; 28(4):291-296.

PMID: 39935755 PMC: 11809567. DOI: 10.5114/wo.2024.144760.

Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use.

Zhang Y, Qiu K, Ren J, Zhao Y, Cheng P Signal Transduct Target Ther. 2025; 10(1):44.

PMID: 39856040 PMC: 11760352. DOI: 10.1038/s41392-024-02083-w.

Nutritional characterization of patients with oropharyngeal cancers: impact of human papillomavirus status.

Choulli M, Kubrak C, Morey F, Brenes J, Tous S, Quiros B Eur J Clin Nutr. 2024; .

PMID: 39738840 DOI: 10.1038/s41430-024-01556-z.

Exosomes in esophageal cancer: function and therapeutic prospects.

Wang C, Shi Z Med Oncol. 2024; 42(1):18.

PMID: 39601925 DOI: 10.1007/s12032-024-02543-x.

A Cross-Sectional Analysis of 2017-2022 National Immunization Survey: Sociodemographic Disparities Associated With Human Papillomavirus Vaccine Initiation and Completion Series Among US Adolescents.

Ibrahim-Ojoawo A, Powe N, Rogers R, Learman K, Hefner H Cancer Control. 2024; 31:10732748241293674.

PMID: 39487812 PMC: 11531671. DOI: 10.1177/10732748241293674.

References

Rischin D, Young R, Fisher R, Fox S, Le Q, Peters L . Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010; 28(27):4142-8. PMC: 2953971. DOI: 10.1200/JCO.2010.29.2904. View

Kimura M, Nagao T, Saito T, Warnakulasuriya S, Ohto H, Takahashi A . Ectopic oral tonsillar tissue: a case series with bilateral and solitary presentations and a review of the literature. Case Rep Dent. 2015; 2015:518917. PMC: 4309306. DOI: 10.1155/2015/518917. View

Vu H, Sikora A, Fu S, Kao J . HPV-induced oropharyngeal cancer, immune response and response to therapy. Cancer Lett. 2009; 288(2):149-55. DOI: 10.1016/j.canlet.2009.06.026. View

Mattox A, Roelands J, Saal T, Cheng Y, Rinchai D, Hendrickx W . Myeloid Cells Are Enriched in Tonsillar Crypts, Providing Insight into the Viral Tropism of Human Papillomavirus. Am J Pathol. 2021; 191(10):1774-1786. PMC: 8491092. DOI: 10.1016/j.ajpath.2021.06.012. View

Quon H, Leong T, Haselow R, Leipzig B, Cooper J, Forastiere A . Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382). Int J Radiat Oncol Biol Phys. 2010; 81(3):719-25. PMC: 3612971. DOI: 10.1016/j.ijrobp.2010.06.038. View

Chera B, Kumar S, Beaty B, Marron D, Jefferys S, Green R . Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer. Clin Cancer Res. 2019; 25(15):4682-4690. PMC: 6679766. DOI: 10.1158/1078-0432.CCR-19-0211. View

Stanley M, Pett M, Coleman N . HPV: from infection to cancer. Biochem Soc Trans. 2007; 35(Pt 6):1456-60. DOI: 10.1042/BST0351456. View

Haddad R, ONeill A, Rabinowits G, Tishler R, Khuri F, Adkins D . Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol. 2013; 14(3):257-64. DOI: 10.1016/S1470-2045(13)70011-1. View

Bernier J, Cooper J, Pajak T, Van Glabbeke M, Bourhis J, Forastiere A . Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005; 27(10):843-50. DOI: 10.1002/hed.20279. View

10.

Ribeiro K, Levi J, Pawlita M, Koifman S, Matos E, Eluf-Neto J . Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol. 2011; 40(2):489-502. DOI: 10.1093/ije/dyq249. View

11.

Bentzen S, Constine L, Deasy J, Eisbruch A, Jackson A, Marks L . Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S3-9. PMC: 3431964. DOI: 10.1016/j.ijrobp.2009.09.040. View

12.

Ragin C, Taioli E . Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007; 121(8):1813-20. DOI: 10.1002/ijc.22851. View

13.

El-Naggar A, Westra W . p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2011; 34(4):459-61. DOI: 10.1002/hed.21974. View

14.

OSullivan B, Huang S, Su J, Garden A, Sturgis E, Dahlstrom K . Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016; 17(4):440-451. DOI: 10.1016/S1470-2045(15)00560-4. View

15.

Sturgis E, Ang K . The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?. J Natl Compr Canc Netw. 2011; 9(6):665-73. DOI: 10.6004/jnccn.2011.0055. View

16.

Vermorken J, Kapteijn T, Hart A, Pinedo H . Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol. 1983; 19(1):53-8. DOI: 10.1016/0277-5379(83)90398-x. View

17.

Vermorken J, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M . Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007; 357(17):1695-704. DOI: 10.1056/NEJMoa071028. View

18.

Gillison M . Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol. 2009; 21(5):439-44. DOI: 10.1097/CCO.0b013e32832f3e1b. View

19.

Overgaard J, Sand Hansen H, Specht L, Overgaard M, Grau C, Andersen E . Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet. 2003; 362(9388):933-40. DOI: 10.1016/s0140-6736(03)14361-9. View

20.

Gelwan E, Malm I, Khararjian A, Fakhry C, Bishop J, Westra W . Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective. Am J Surg Pathol. 2017; 41(12):1722-1728. DOI: 10.1097/PAS.0000000000000929. View